IC50-to-Ki: a web-based tool for converting IC50 to Ki values for inhibitors of enzyme activity and ligand binding
TLDR
A new web-server tool estimates Ki values from experimentally determined IC50 values for inhibitors of enzymes and of binding reactions between macromolecules and ligands to enable end users to help gauge the quality of the underlying assumptions used in these calculations.Abstract:
A new web-server tool estimates Ki values from experimentally determined IC50 values for inhibitors of enzymes and of binding reactions between macromolecules (e.g. proteins, polynucleic acids) and ligands. This converter was developed to enable end users to help gauge the quality of the underlying assumptions used in these calculations which depend on the type of mechanism of inhibitor action and the concentrations of the interacting molecular species. Additional calculations are performed for nonclassical, tightly bound inhibitors of enzyme-substrate or of macromolecule-ligand systems in which free, rather than total concentrations of the reacting species are required. Required userdefined input values include the total enzyme (or another target molecule) and substrate (or ligand) concentrations, the Km of the enzyme-substrate (or the Kd of the target-ligand) reaction, and the IC50 value. Assumptions and caveats for these calculations are discussed along with examples taken from the literature. The host database for this converter contains kinetic constants and other data for inhibitors of the proteolytic clostridial neurotoxins (http:// botdb.abcc.ncifcrf.gov/toxin/kiConverter.jsp).read more
Citations
More filters
Journal ArticleDOI
Biological evaluation of 9-( 1H -Indol-3-yl) xanthen-4-( 9H )-ones derivatives as noncompetitive α-glucosidase inhibitors: kinetics and molecular mechanisms
Maryam Nourisefat,Najmeh Salehi,Saeed Yousefinejad,Farhad Panahi,Kowsar Bagherzadeh,Massoud Amanlou,Ali Khalafi-Nezhad,Mohammad Hossein Karimi-Jafari,Nader Sheibani,Ali Akbar Moosavi-Movahedi +9 more
TL;DR: The studies provide important molecular mechanisms delineating α-Glucosidase inhibition, which could aid in development of new drugs for type 2 diabetes mellitus treatment, and show that the electronegative and oxygen-containing functional groups of indolyl-xanthone structures play a significant role in low-to-moderate inhibitory properties of these potentially anti-diabetic drugs against α- GlucosIDase enzyme.
Patent
Antibodies that inhibit metalloproteins
TL;DR: In this paper, an application relates to antibodies which recognize [2 (2 -aminoethylcarbomoyl) - ethoxymethyl] -tris- [2-N- (3 - imidazol - 1 -yl -propyl) ) -etho xymethyl], a hapten molecule which closely mimics the local structure and conformation of the reactive zinc site in matrix metalloproteinases.
Journal ArticleDOI
New glucose-6-phosphate dehydrogenase inhibitor from the Red Sea sponge Echinoclathria sp
Reda F. A. Abdelhameed,Eman S. Habib,Nermeen A. Eltahawy,Hashim A. Hassanean,Amany K. Ibrahim,John Refaat Fahim,Ahmed M. Sayed,Omnia Magdy Hendawy,Usama Ramadan Abdelmohsen,Safwat A. Ahmed +9 more
TL;DR: The in vitro cytotoxic activity of the isolated compounds was tested against three human cancer cell lines, MCF-7, HepG2, and HeLa, and showed strong to moderate cytotoxicity with IC50 values ranged from 3.23 to 28.1 µM.
Journal ArticleDOI
In Vitro and In Vivo Assessment of Metabolic Drug Interaction Potential of Dutasteride with Ketoconazole.
Seong-Wook Seo,Jin Woo Park,Dong-Gyun Han,Ji-Min Kim,Sanghyun Kim,Taeuk Park,Kyung-Hwa Kang,Min Hye Yang,In-Soo Yoon +8 more
TL;DR: This is the first study to show the drug interaction potential of Dutasteride with azole antifungal drugs including KET, together with a newly developed HPLC-FL method for the simultaneous quantification of DUT and H-DUT.
Journal ArticleDOI
Inhibitor-conjugated harmonic nanoparticles targeting fibroblast activation protein
Raphaël De Matos,Jérémy Vuilleumier,Christophe Mas,Samuel Constant,Davide Staedler,Sandrine Gerber-Lemaire +5 more
TL;DR: A low molecular weight ligand targeting fibroblast activation protein α (FAP), which is specifically expressed by activated fibroblasts of the tumor stroma, was synthesized and demonstrated nanomolar inhibition of FAP with high selectivity with respect to prolyl oligopeptidase (PREP) and dipeptidyl peptidase IV, as well as good biocompatibility toward a human lung tissue model.
References
More filters
Journal ArticleDOI
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.
TL;DR: The analysis described shows K I does not equal I 50 when competitive inhibition kinetics apply; however, K I is equal to I 50 under conditions of either noncompetitive or uncompetitive kinetics.
Journal ArticleDOI
Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization
Zaneta Nikolovska-Coleska,Renxiao Wang,Xueliang Fang,Hongguang Pan,York Tomita,Peng Li,Peter P. Roller,Krzysztof Krajewski,Naoyuki G. Saito,Jeanne A. Stuckey,Shaomeng Wang +10 more
TL;DR: The development of a homogeneous high-throughput assay based on fluorescence polarization for measuring the binding affinities of small-molecule inhibitors to the BIR3 domain of XIAP and results obtained indicated that the FP-based competitive binding assay performs correctly as designed.
Journal ArticleDOI
A linear equation that describes the steady-state kinetics of enzymes and subcellular particles interacting with tightly bound inhibitors.
TL;DR: D dose-response measurements generate a linear plot of inhibitor concentration divided by degree of inhibition against velocity without inhibitor divided by velocity with inhibitor, which indicates that the inhibitors of oxidative phosphorylation, rutamycin and bongkrekic acid, are tightly bound to rat liver mitochondria.
Journal ArticleDOI
BRENDA, AMENDA and FRENDA the enzyme information system: new content and tools in 2009
TL;DR: The web service via a SOAP (Simple Object Access Protocol) interface for access to the BRENDA data has been further enhanced and a new search option provides the access to protein-specific data.
Journal ArticleDOI
Fluorescence Polarization Competition Assay: The Range of Resolvable Inhibitor Potency Is Limited by the Affinity of the Fluorescent Ligand
TL;DR: The higher the affinity of the fluorescent ligand, the wider the range of inhibitor potency that can be resolved, and an approximate estimate for the low end of inhibitor K(i) values thatCan be resolved is the K(d) value of theorescent ligand.